HUMASIS CO., LTD. Logo

HUMASIS CO., LTD.

Manufactures in-vitro diagnostic (IVD) devices for Point-of-Care Testing (POCT).

205470 | KO

Overview

Corporate Details

ISIN(s):
KR7205470008
LEI:
Country:
South Korea
Address:
경기도 안양시 동안구 전파로 88 신원비젼타워 114호.502호.504호.604호.604-1호.비03-1호.비03-2호, 안양시

Description

Humasis Co., Ltd. is a company specializing in the research, development, and manufacturing of in-vitro diagnostic (IVD) devices, with a primary focus on Point-of-Care Testing (POCT). The company develops and produces a range of rapid diagnostic solutions, including immunodiagnostic kits for the early screening of various diseases, compact instruments for quantitative analysis, and personal health care products. A key operational strength is the in-house development and production of critical bio-materials, such as diagnostic immune antigens, which ensures the consistent performance and accuracy of its products. Humasis aims to provide technologies for precise and rapid disease analysis to support clinical decision-making and promote individual health management.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-05-18 00:00
주요사항보고서(자기주식취득결정)
Korean 28.1 KB
2023-05-12 00:00
분기보고서 (2023.03)
Korean 1.5 MB
2023-05-10 00:00
주요사항보고서(소송등의제기)
Korean 5.1 KB
2023-04-10 00:00
주식등의대량보유상황보고서(약식)
Korean 60.7 KB
2023-03-31 00:00
주식등의대량보유상황보고서(일반)
Korean 87.0 KB
2023-03-31 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.4 KB
2023-03-29 00:00
신탁계약해지결과보고서
Korean 14.1 KB
2023-03-28 00:00
[기재정정]주요사항보고서(소송등의제기)
Korean 12.6 KB
2023-03-24 00:00
소송등의판결ㆍ결정
Korean 5.4 KB
2023-03-23 00:00
권리락(무상증자)
Korean 3.5 KB
2023-03-22 00:00
소송등의판결ㆍ결정(일정금액이상의청구)
Korean 8.2 KB
2023-03-17 00:00
정기주주총회결과
Korean 31.9 KB
2023-03-17 00:00
투자판단관련주요경영사항(경영지배인 사임)
Korean 5.7 KB
2023-03-17 00:00
대표이사변경
Korean 9.8 KB
2023-03-17 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 12.1 KB

Automate Your Workflow. Get a real-time feed of all HUMASIS CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HUMASIS CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HUMASIS CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.